Search Results

Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas

Authors: Caruso, Gerardo; Caffo, Mariella; Raudino, Giuseppe; Alafaci, Concetta; Salpietro, Francesco M.; Tomasello, Francesco

Source: Recent Patents on CNS Drug Discovery, Volume 5, Number 1, January 2010 , pp. 53-69(17)

Publisher: Bentham Science Publishers

Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-κB encapsulated albumin microspheres

Authors: Gayakwad, Sanjay G.; Bejugam, Naveen K.; Akhavein, Nima; Uddin, Nasir A.; Oettinger, Carl E; D'Souza, Martin J.

Source: Journal of Microencapsulation, Volume 26, Number 8, December 2009 , pp. 692-700(9)

Publisher: Informa Healthcare

Assessment of the swine protein-annotated oligonucleotide microarray

Authors: Steibel, J. P.; Wysocki, M.; Lunney, J. K.; Ramos, A. M.; Hu, Z.-L.; Rothschild, M. F.; Ernst, C. W.

Source: Animal Genetics, Volume 40, Number 6, December 2009 , pp. 883-893(11)

Publisher: Blackwell Publishing

Treatment of malignant gliomas with TGF-β2 antisense oligonucleotides

Authors: Hau, Peter; Jachimczak, Piotr; Bogdahn, Ulrich

Source: Expert Review of Anticancer Therapy, Volume 9, Number 11, November 2009 , pp. 1663-1674(12)

Publisher: Expert Reviews

Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer

Authors: Sternberg, C. N.; Dumez, H.; Van Poppel, H.; Skoneczna, I.; Sella, A.; Daugaard, G.; Gil, T.; Graham, J.; Carpentier, P.; Calabro, F.; Collette, L.; Lacombe, D.

Source: Annals of Oncology, Volume 20, Number 7, 10 July 2009 , pp. 1264-1269(6)

Publisher: Oxford University Press

Organic Synthesis and Antisense Effects of Oligonucleotide-Peptide Conjugates

Authors: Murao, Satoshi; Fujii, Masayuki

Source: Current Organic Chemistry, Volume 13, Number 14, September 2009 , pp. 1366-1377(12)

Publisher: Bentham Science Publishers

Tolerability and safety of GS-101 eye drops, an antisense oligonucleotide to insulin receptor substrate-1: a `first in man' Phase I investigation

Authors: Kain, Hermann; Goldblum, David; Geudelin, Bernard; Thorin, Eric; Beglinger, Christoph

Source: British Journal of Clinical Pharmacology, Volume 68, Number 2, August 2009 , pp. 169-173(5)

Publisher: Blackwell Publishing

Exon-skipping therapy for Duchenne muscular dystrophy

Authors: Nakamura, Akinori; Takeda, Shin'ichi

Source: Neuropathology, Volume 29, Number 4, August 2009 , pp. 494-501(8)

Publisher: Blackwell Publishing

Treatment of adjuvant arthritis using microencapsulated antisense NF-κB oligonucleotides

Authors: Akhavein, Nima; Oettinger, Carl; Gayakwad, Sanjay; Addo, Richard; Bejugam, Naveen; Bauer, John; Do, Duc; Pollock, Stanley; D'souza, Martin

Source: Journal of Microencapsulation, Volume 26, Number 3, May 2009 , pp. 223-234(12)

Publisher: Informa Healthcare

Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats

Authors: Ropelle, Eduardo R.; Pauli, José R.; Prada, Patrícia; Cintra, Dennys E.; Rocha, Guilherme Z.; Moraes, Juliana C.; Frederico, Marisa J. S.; da Luz, Gabrielle; Pinho, Ricardo A.; Carvalheira, José B. C.; Velloso, Licio A.; Saad, Mario A.; De Souza, Cláudio T.

Source: The Journal of Physiology, Volume 587, Number 10, May 2009 , pp. 2341-2351(11)

Publisher: Blackwell Publishing

Oligonucleotide based-strategies for allergy with special reference to siRNA

Authors: Suzuki, Motohiko; Zheng, Xiufen; Zhang, Xusheng; Ichim, Thomas E; Beduhn, Marianne E; Min, Weiping

Source: Expert Opinion on Biological Therapy, Volume 9, Number 4, April 2009 , pp. 441-450(10)

Publisher: Informa Healthcare

Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma

Authors: Chanan-Khan, Asher; Niesvizky, Ruben; Hohl, Raymond; Zimmerman, Todd; Christiansen, Neal; Schiller, Gary; Callander, Natalie; Lister, John; Oken, Martin; Jagannath, Sundar

Source: Leukemia and Lymphoma, Volume 50, Number 4, April 2009 , pp. 559-565(7)

Publisher: Informa Healthcare

Antisense oligonucleotide pharmacokinetics and metabolism

Author: Geary, Richard S

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 4, April 2009 , pp. 381-391(11)

Publisher: Informa Healthcare

Size-Uniform 200 nm Particles: Fabrication and Application to Magnetofection

Authors: Mair, Lamar; Ford, Kris; Alam, Md. Rowshon; Kole, Ryszard; Fisher, Michael; Superfine, Richard

Source: Journal of Biomedical Nanotechnology, Volume 5, Number 2, April 2009 , pp. 182-191(10)

Publisher: American Scientific Publishers

Antisense oligonucleotide targeting Bcl-2 messenger RNA in cancer: bad drug, bad target, neither or both?

Authors: Loriot, Y.; Mordant, P.; Deutsch, E.

Source: Annals of Oncology, Volume 20, Number 3, 12 March 2009 , pp. 596-597(2)

Publisher: Oxford University Press

Reply to Antisense oligonucleotide targeting Bcl-2 mRNA in cancer; bad drug, bad target, neither or both?

Author: Palmieri, G.

Source: Annals of Oncology, Volume 20, Number 3, 12 March 2009 , pp. 597-597(1)

Publisher: Oxford University Press

Roles of protein kinase Cα isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression

Authors: Kuo, Dong-Yih; Yang, Shun-Fa; Chu, Shu-Chen; Chen, Chin-Hsiu; Hsieh, Yih-Shou

Source: Journal of Neurochemistry, Volume 108, Number 6, March 2009 , pp. 1495-1506(12)

Publisher: Blackwell Publishing

DNAzyme Delivery Systems: Getting Past First Base

Authors: Lin Tan, Mei; Choong, Peter FM; Dass, Crispin R

Source: Expert Opinion on Drug Delivery, Volume 6, Number 2, February 2009 , pp. 127-138(12)

Publisher: Informa Healthcare

Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides

Authors: Han, Su-Eun; Kang, Hyungu; Shim, Ga Yong; Kim, Sun Jae; Choi, Han-Gon; KIM, JISEOK; HAHN, SEI KWANG; Oh, Yu-Kyoung

Source: Journal of Drug Targeting, Volume 17, Number 2, February 2009 , pp. 123-132(10)

Publisher: Informa Healthcare

Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2′-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe

Authors: Yu, Rosie Z.; Geary, Richard S.; Flaim, JoAnn D.; Riley, Gina C.; Tribble, Diane L.; vanVliet, André A.; Wedel, Mark K.

Source: Clinical Pharmacokinetics, Volume 48, Number 1, 2009 , pp. 39-50(12)

Publisher: Adis International